ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Epidemiologic methods"

  • Abstract Number: 1715 • 2013 ACR/ARHP Annual Meeting

    Detection Of Enthesitis In Children With Enthesitis-Related Arthritis: Dolorimeter Examination Compared To Ultrasonography

    Pamela F. Weiss1, Nancy Chauvin2, Andrew J. Klink3, Russell A. Localio4, Chris Feudtner5, Diego Jaramillo2, Robert A. Colbert6, David D. Sherry7 and Ron Keren3, 1Rheumatology, The Children's Hospital of Philadelphia, Philadelphia, PA, 2Radiology, Children's Hospital of Philadelphia, PHILADELPHIA, PA, 3Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, 4Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 5Division of General Pediatrics, Children's Hospital of Philadelphia; University of Pennsylvania Center for Clinical Epidemiology and Biostatistics, Philadelphia, PA, 6NIAMS/NIH, Bethesda, MD, 7Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: To evaluate the distribution of enthesitis and accuracy of physical examination (PE) for the detection of enthesitis in children, using ultrasound with power Doppler…
  • Abstract Number: 782 • 2013 ACR/ARHP Annual Meeting

    Rates Of Malignancies In Patients From 5 Rheumatoid Arthritis Registries Across The World

    Johan Askling1, Niklas Berglind2, Stefan Franzén2, Thomas Frisell3, Christopher Garwood4, Jeffrey D. Greenberg5, Meilien Ho6, Marie Holmqvist1, Laura Horne7, Kathy Lampl8, Kaleb Michaud9, Fredrik Nyberg10, Dimitrios A. Pappas11, George Reed12, Eiichi Tanaka13, Trung Tran14, Suzanne Verstappen4, Hisashi Yamanaka15 and Deborah Symmons4, 1Karolinska Institutet, Stockholm, Sweden, 2AstraZeneca R&D Mölndal, Mölndal, Sweden, 3Clinical Epidemiology Unit, Dept of Medicine, Karolinska Institutet, Stockholm, Sweden, 4Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester, United Kingdom, 5Division of Rheumatology, Department of Medicine, NYU Hospital for Joint Diseases, New York, NY, 6AstraZeneca R&D Alderley Park, Macclesfield, United Kingdom, 7AstraZeneca, Wilmington, DE, 8AstraZeneca R&D Wilmington, Wilmington, DE, 9University of Nebraska Medical Center and National Data Bank, Omaha, NE, 10AstraZeneca R&D, Mölndal, Sweden, 11Columbia University, New York, NY, 12University of Massachusetts Medical School, Worcester, MA, 13Tokyo Women's Medical University, Tokyo, Japan, 14MedImmune LLC, Gaithersburg, MD, 15Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan

    Background/Purpose: The overall incidence of cancer in patients with rheumatoid arthritis (RA) is modestly elevated compared with the general population. The extent to which cancer…
  • Abstract Number: 1351 • 2013 ACR/ARHP Annual Meeting

    A Comparison Of The Clinical Effectiveness Of Treatment Strategies For Active RA Patients : Using a Prospective Biologic Registry (BIOPSY) and an RA Specific Cohort (KORONA)

    Yoon-Kyoung Sung1,2, Soo-Kyung Cho1,2, Chan-Bum Choi3,4, Soyoung Won5, So-Young Bang6, Hoon-Suk Cha7, Jung-Yoon Choe8, Won Tae Chung9, Seung-Jae Hong10, Jae-Bum Jun4, Hyoun Ah Kim11, Jinseok Kim12, Seong-Kyu Kim8, Tae-Hwan Kim4, Hye-Soon Lee13, Jaejoon Lee7, Jisoo Lee14, Shin-Seok Lee15, Sung Won Lee16, Yeon-Ah Lee10, Seong-Su Nah17, Chang-Hee Suh18, Dae-Hyun Yoo4, Bo Young Yoon19 and Sang-Cheol Bae1,2, 1Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 2Department of Rheumatology, Clinical Research Center for Rheumatoid Arthritis (CRCRA), Seoul, South Korea, 3Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Clinical Research Center for Rheumatoid Arthritis (CRCRA), Seoul, South Korea, 4Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 5Clinical Research Center for Rheumatoid Arthritis (CRCRA), Seoul, South Korea, 6Hanyang University Guri Hospital, Guri, South Korea, 7Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 8Catholic University of Daegu School of Medicine, Daegu, South Korea, 9Division of Rheumatology, Department of Internal Medicine, Dong-A University Hospital, Busan, South Korea, 10Division of Rheumatology, Department of Internal Medicine, Kyung Hee University, Seoul, South Korea, 11Ajou University Hospital, Suwon, South Korea, 12Division of Rheumatology, Internal Medicine, Jeju National University Hospital, Jeju, Korea, South Korea, 13Department of Rheumatology, Hanyang University Guri Hospital, Guri, South Korea, 14Internal Medicine, Ewha Womans University Mokdong Hospital, Seoul, South Korea, 15Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, South Korea, 16Rheumatology, Dong-A University Hospital, Busan, South Korea, 17Division of Rheumatology, Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, South Korea, 18Department of Rheumatology, Ajou University Hospital, Suwon, South Korea, 19Inje University Ilsan Paik Hospital, Goyang, South Korea

    Background/Purpose: The results from RCTs may not be generalizable to clinical practice because of their inclusion and exclusion criteria. Instead, observational cohorts and registries might…
  • Abstract Number: 303 • 2013 ACR/ARHP Annual Meeting

    Risk Of Cardiovascular Events In Patients With Psoriatic Arthritis, Psoriasis, and Rheumatoid Arthritis: A General Population-Based Cohort Study

    Alexis Ogdie1, Yiding Yu2, Kevin Haynes3, Samantha Maliha4, Thorvardur Love5,6, Andrea Troxel7, Sean Hennessy8, David Margolis9, Stephen Kimmel10, Nehal N. Mehta11, Hyon Choi12,13 and Joel Gelfand14, 1Rheumatology and Epidemiology, University of Pennsylvania, Philadelphia, PA, 2Medicine, Brigham and Women's Hospital, Boston, MA, 3Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 4University of Pennsylvania, Philadelphia, PA, 5Faculty of Medicine, University of Iceland, Reykjavik, Iceland, 6Landspitali University Hospital, Reykjavik, Iceland, 7Biostatistics and Epidemiology, University of Pennsylvania., Philadelphia, PA, 8Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA, 9Dermatology and Epidemiology, University of Pennsylvania, Philadelphia, PA, 10Cardiology and Epidemiology, University of Pennsylvania, Philadelphia, PA, 11National Heart Lung Blood Institute, Cardiovascular and Pulmonary Division, NHLBI, National Institutes of Health, Bethesda, MD, 12Section of Rheumatology and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 13Division of Rheumatology, Allergy, and Immunology Massachusetts General Hospital, Harvard Medical School, Boston, MA, 14Dermatology and Epidemiology, University of Pennsylvania., Philadelphia, PA

    Risk of Cardiovascular Events in Patients with Psoriatic Arthritis, Psoriasis, and Rheumatoid Arthritis: A general population-based cohort studyBackground/Purpose: Psoriatic arthritis (PsA), psoriasis, and rheumatoid arthritis…
  • Abstract Number: 1271 • 2013 ACR/ARHP Annual Meeting

    Longitudinal Disease Trajectory Of Juvenile Dermatomyositis

    Lily Siok Hoon Lim1,2, Eleanor Pullenayegum3, Dafna D. Gladman4, Earl D. Silverman5 and Brian M. Feldman6, 1Pediatric Rheumatology, Hospital for Sick Children, Toronto, ON, Canada, 2Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, ON, Canada, 3Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada, 4Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 5Rheumatology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada, 6Rheumatology, Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose: 1) To determine the longitudinal disease activity trajectory of an inception cohort of Juvenile Dermatomyositis (JDM) patients, 2) To identify predictor(s) for longitudinal disease…
  • Abstract Number: 261 • 2013 ACR/ARHP Annual Meeting

    Concordance Of Hip Pain With Radiographic Hip Osteoarthritis In An Urban US Community: The Framingham Osteoarthritis Study

    Kyu Chan Kim1, David T. Felson2, Katherine D. Linsenmeyer3, Ali Guermazi4, Steven C. Vlad5, Mary M. Clancy6 and Jingbo Niu7, 1Internal Medicine and Rheumatology, Boston Medical Center, Boston, MA, 2Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 3Internal Medicine, Boston Medical Center, Boston, MA, 4Boston University, Boston, MA, 5Clinical Epidemiology, Boston University, Boston, MA, 6School of Medicine, Boston University, Boston, MA, 7Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA

    Background/Purpose: While it is well known that knee pain and radiographic knee osteoarthritis (OA) are often discordant, little is known of the concordance of hip…
  • Abstract Number: 2462 • 2012 ACR/ARHP Annual Meeting

    Projecting the Direct Cost Burden of Osteoarthritis in Canada Using a Population-Based Microsimulation Model From [2010-2031]

    Behnam Sharif1, Jacek A. Kopec2, Mushfiqur Rahman3, Nick Bansback4, Eric C. Sayre2, Philippe Finès5, Hubert Wong6 and Aslam H. Anis4, 1School of Population and Public Health, University of British Columbia, Arthritis Research Centre of Canada, Vancouver, BC, Canada, 2Arthritis Research Centre of Canada, Vancouver, BC, Canada, 3Rheumatology, Arthritis Research Centre of Canada, Vancouver, BC, Canada, 4St. Paul's Hospital, Centre for Health Evaluation and Outcome Sciences, Vancouver, BC, Canada, 5Statistics Canada, 150 Tunney's Pasture Driveway, Ottawa, ON, Canada, Ottawa, ON, Canada, 6School of Population and Public Health, University of British Columbia, St Paul's Hospital, University of British Columbia, Vancouver, V6Z 1Y6, Canada, Vancouver, BC, Canada

    Background/Purpose: POHEM-OA (Population Health Model-Osteoarthritis) is a population-based microsimulation model that uses Canadian Community Health Survey-2001 to generate the initial population and models every individual's…
  • Abstract Number: 65 • 2012 ACR/ARHP Annual Meeting

    Serum Inflammatory Biomarkers Correlated Stronger with a Panel of Serum Steroid and Pituitary Hormones in a Cohort of Pre-Rheumatoid Arthritis (pre-RA) Than in Non-RA Control (CN) Subjects

    Alfonse T. Masi1, Kevin B. Elmore1, Azeem A. Rehman1, Jean C. Aldag1 and Robert T. Chatterton2, 1Medicine, University of Illinois College of Medicine at Peoria, Peoria, IL, 2Obstetrics and Gynecology and Physiology, Northwestern University, Chicago, IL

    Background/Purpose: Inflammatory cytokines influence steroid hormone production in tissue culture and affect serum levels and synovial fluid of active RA patients.  Inflammatory biomarker and hormonal…
  • Abstract Number: 2134 • 2012 ACR/ARHP Annual Meeting

    The Changed Prognosis of Patients with Early Rheumatoid Arthritis

    Karin Britsemmer1 and Dirkjan van Schaardenburg2, 1Rheumatology, Jan van Breemen Research Institute / Reade, Amsterdam, Netherlands, 2Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands

    The Changed Prognosis of Patients with Early Rheumatoid Arthritis Background/Purpose: The treatment of rheumatoid arthritis (RA) has changed greatly during the past fifteen to twenty…
  • Abstract Number: 1642 • 2012 ACR/ARHP Annual Meeting

    Biologics and Mortality Risk in Rheumatoid Arthritis – Results of a Population Based Study

    Diane Lacaille1, Michal Abrahamowicz2, Eric C. Sayre3 and John Esdaile4, 1Rheumatology, Arthritis Research Centre of Canada, University of British Columbia, Richmond, BC, Canada, 2Clinical Epidemiology, McGill University, Montreal, QC, Canada, 3Arthritis Research Centre of Canada, Vancouver, BC, Canada, 4Rheumatology, Arthritis Research Centre of Canada, University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: Biologic agents, due to their effect on disease activity, may reduce the risk of premature mortality in rheumatoid arthritis (RA). We evaluated the association…
  • Abstract Number: 1128 • 2012 ACR/ARHP Annual Meeting

    Different of Patterns Knee Pain Trajectories: Longitudinal Data From the Osteoarthritis Initiative (OAI)

    Joseph Devich Jr.1, Michael J. Hannon2, Zhijie Wang2, Robert M. Boudreau3 and C. Kent Kwoh4, 1Imrp, UPMC Shadyside​, Pittsburgh, PA, 2Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, 3Epidemiology, University of Pittsburgh, Pittsburgh, PA, 4School of Medicine, Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Knee osteoarthritis (KOA) is one of the most common forms of arthritis and the most common cause of disability among the elderly.  Knee pain…
  • Abstract Number: 1088 • 2012 ACR/ARHP Annual Meeting

    Factors Influencing Long-Term Recovery of Total Knee Arthroplasty

    C. Allyson Jones1, Gian S. Jhangri2 and Maria E. Suarez-Almazor3, 1Departments of Physical Therapy and School of Public Health, University of Alberta, Edmonton, AB, Canada, 2School of Public Health, University of Alberta, Edmonton, AB, Canada, 3The Department of General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX

    Background/Purpose: Although a number of studies have examined short term outcomes after total knee arthroplasty (TKA), few have prospectively examined the long term trajectory of…
  • Abstract Number: 1016 • 2012 ACR/ARHP Annual Meeting

    The Effect of Evaluation Variability At the Unit of Measurement On the Reliability of Omeract Ramris and Van Der Heijde-Modified Sharp Score

    Ruben Tavares1, Naveen Parasu2, Karen Finlay3, Erik Jurriaans3, Hao Wu1, Karen A. Beattie4, Maggie Larche5, Lawrence E. Hart6, William G. Bensen7, Raja S. Bobba5, Alfred A. Cividino4, Colin E. Webber8, Jean-Eric Tarride9 and Jonathan D. Adachi10, 1McMaster University, Hamilton, ON, Canada, 2Radiology, Hamilton Health Sciences, Hamilton, ON, 3Radiology, Hamilton Health Sciences, Hamilton, ON, Canada, 4Medicine, McMaster University, Hamilton, ON, Canada, 5Rheumatology, McMaster University, Hamilton, ON, Canada, 6Medicine (Rheumatology), St. Joseph's Health Care, Hamilton, ON, Canada, 7Department of Medicine, Division of Rheumatology, St. Joseph's Hospital and McMaster University, Hamilton, ON, Canada, 8Department of Nuclear Medicine, Hamilton Health Sciences, Hamilton, ON, Canada, 9Clinical Epidemiology and Biostatistics (CE&B) and Economics, Programs for Assessment of Technology in Health (PATH) Research Institute, Hamilton, ON, Canada, 10St Joseph's Healthcare Hamilton, Hamilton, ON, Canada

    Background/Purpose: The Outcome Measures in Rheumatology (OMERACT) Rheumatoid Arthritis Magnetic Resonance Imaging Score (RAMRIS) and van der Heijde-modified Sharp score (vdHSS) are recognized semi-quantitative measures…
  • Abstract Number: 1001 • 2012 ACR/ARHP Annual Meeting

    CNstream2: Improved SNP and CNV Genotyping Reveals New Loci Associated with Rheumatic Diseases

    Arnald Alonso, Antonio Julià, Raül Tortosa and Sara Marsal, Rheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain

    Background/Purpose: In Genome-Wide Association Studies (GWAS), the performance of the genotyping algorithm is crucial to identify new SNPs associated to disease risk. Recently, new methods…
  • Abstract Number: 951 • 2012 ACR/ARHP Annual Meeting

    A Systematic Review of Quality of Prognosis Studies in Systemic Lupus Erythematosus

    Lily Siok Hoon Lim1, Senq-J Lee2, Brian M. Feldman3, D. D. Gladman4, Eleanor Pullenayegum5 and Earl D. Silverman6, 1Pediatric Rheumatology, Hospital for Sick Children, Toronto, ON, Canada, 2Division of Rheumatology, Hospital for Sick Children, Toronto, ON, Canada, 3Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 4Division of Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, 5Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, ON, Canada, 6Rheumatology, Pediatric Rheumatology Collaborative Study Group (PRSCG), Toronto, ON, Canada

    Background/Purpose: Prognosis studies study future outcomes and/or seek to identify predictive or associative factors associated with outcomes. Strong and consistent prognostic factors can be used…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology